Literature DB >> 19074705

Treatment and prevention of herpes labialis.

Wim Opstelten1, Arie Knuistingh Neven, Just Eekhof.   

Abstract

OBJECTIVE: To review the evidence regarding the treatment and prevention of herpes labialis. QUALITY OF EVIDENCE: The evidence relating to treatment and prevention of herpes labialis is derived from randomized controlled trials (level I evidence). MAIN MESSAGE: Treatment with an indifferent cream (zinc oxide or zinc sulfate), an anesthetic cream, or an antiviral cream has a small favourable effect on the duration of symptoms, if applied promptly. This is also the case with oral antiviral medication. If antiviral medicine (cream or oral) is started before exposure to the triggering factor (sunlight), it will provide some protection. Research on sunscreens has shown mixed results: some protection has been reported under experimental conditions that could not be replicated under natural conditions. In the long term, the number of relapses of herpes labialis can be limited with oral antiviral medication.
CONCLUSION: Only prompt topical or oral therapy will alleviate symptoms of herpes labialis. Both topical and oral treatment can contribute to the prevention of herpes labialis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19074705      PMCID: PMC2602638     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  40 in total

1.  High-dose, short-duration, early valacyclovir therapy for episodic treatment of cold sores: results of two randomized, placebo-controlled, multicenter studies.

Authors:  Spotswood L Spruance; Terry M Jones; Mark M Blatter; Mauricio Vargas-Cortes; Judy Barber; Joanne Hill; Donna Goldstein; Margaret Schultz
Journal:  Antimicrob Agents Chemother       Date:  2003-03       Impact factor: 5.191

2.  Longitudinal study of genital infection by herpes simplex virus type 1 in Western Scotland over 15 years.

Authors:  Anne Scoular; John Norrie; Graeme Gillespie; Noreen Mir; W F Carman
Journal:  BMJ       Date:  2002-06-08

3.  Genital herpes and public health: addressing a global problem.

Authors:  L Corey; H H Handsfield
Journal:  JAMA       Date:  2000-02-09       Impact factor: 56.272

Review 4.  Treatment of herpes simplex labialis.

Authors:  Spotswood L Spruance; John D Kriesel
Journal:  Herpes       Date:  2002-12

5.  [Clinical double-blind trial of topical zinc sulfate for herpes labialis recidivans].

Authors:  W Kneist; B Hempel; S Borelli
Journal:  Arzneimittelforschung       Date:  1995-05

6.  Valacyclovir for prevention of recurrent herpes labialis: 2 double-blind, placebo-controlled studies.

Authors:  David Baker; Drore Eisen
Journal:  Cutis       Date:  2003-03

7.  A randomized clinical trial on the treatment of oral herpes with topical zinc oxide/glycine.

Authors:  H R Godfrey; N J Godfrey; J C Godfrey; D Riley
Journal:  Altern Ther Health Med       Date:  2001 May-Jun       Impact factor: 1.305

Review 8.  The many challenges of facial herpes simplex virus infection.

Authors:  J Esmann
Journal:  J Antimicrob Chemother       Date:  2001-02       Impact factor: 5.790

9.  Acyclovir cream for treatment of herpes simplex labialis: results of two randomized, double-blind, vehicle-controlled, multicenter clinical trials.

Authors:  Spotswood L Spruance; Robert Nett; Thomas Marbury; Ray Wolff; James Johnson; Theodore Spaulding
Journal:  Antimicrob Agents Chemother       Date:  2002-07       Impact factor: 5.191

10.  Double-blind, randomized, placebo-controlled study of topical 5% acyclovir-1% hydrocortisone cream (ME-609) for treatment of UV radiation-induced herpes labialis.

Authors:  T G Evans; D I Bernstein; G W Raborn; J Harmenberg; J Kowalski; S L Spruance
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

View more
  25 in total

1.  Prevention of recurrent herpes labialis outbreaks through low-intensity laser therapy: a clinical protocol with 3-year follow-up.

Authors:  Carlos de Paula Eduardo; Letícia Mello Bezinelli; Fernanda de Paula Eduardo; Roberta Marques da Graça Lopes; Karen Müller Ramalho; Marina Stella Bello-Silva; Marcella Esteves-Oliveira
Journal:  Lasers Med Sci       Date:  2011-11-16       Impact factor: 3.161

Review 2.  Current management and recommendations for access to antiviral therapy of herpes labialis.

Authors:  Anthony Cunningham; Paul Griffiths; Peter Leone; Adrian Mindel; Rajul Patel; Lawrence Stanberry; Richard Whitley
Journal:  J Clin Virol       Date:  2011-09-01       Impact factor: 3.168

Review 3.  Herpes labialis.

Authors:  Graham Worrall
Journal:  BMJ Clin Evid       Date:  2009-09-23

4.  Immunotherapy of Recurrent Herpes Labialis With Squaric Acid.

Authors:  Maria Alora Palli; Hugh McTavish; Alexa Kimball; Thomas D Horn
Journal:  JAMA Dermatol       Date:  2017-08-01       Impact factor: 10.282

Review 5.  Laser treatment of recurrent herpes labialis: a literature review.

Authors:  Carlos de Paula Eduardo; Ana Cecilia Corrêa Aranha; Alyne Simões; Marina Stella Bello-Silva; Karen Muller Ramalho; Marcella Esteves-Oliveira; Patrícia Moreira de Freitas; Juliana Marotti; Jan Tunér
Journal:  Lasers Med Sci       Date:  2013-04-13       Impact factor: 3.161

6.  Review of Whole Plant Extracts With Activity Against Herpes Simplex Viruses In Vitro and In Vivo.

Authors:  Anna Garber; Lianna Barnard; Chris Pickrell
Journal:  J Evid Based Integr Med       Date:  2021 Jan-Dec

7.  Guideline for the Management Herpes Simplex 1 and Cosmetic Interventions.

Authors:  Devan Vaghela; Emma Davies; Gillian Murray; Cormac Convery; Lee Walker
Journal:  J Clin Aesthet Dermatol       Date:  2021-06-01

8.  Prophylactic, therapeutic and neutralizing effects of zinc oxide tetrapod structures against herpes simplex virus type-2 infection.

Authors:  Thessicar E Antoine; Yogendra K Mishra; James Trigilio; Vaibhav Tiwari; Rainer Adelung; Deepak Shukla
Journal:  Antiviral Res       Date:  2012-10-06       Impact factor: 5.970

Review 9.  Autophagy interaction with herpes simplex virus type-1 infection.

Authors:  Douglas O'Connell; Chengyu Liang
Journal:  Autophagy       Date:  2016-03-02       Impact factor: 16.016

Review 10.  Transdermal drug delivery systems for fighting common viral infectious diseases.

Authors:  Fang-Ying Wang; Yunching Chen; Yi-You Huang; Chao-Min Cheng
Journal:  Drug Deliv Transl Res       Date:  2021-05-22       Impact factor: 4.617

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.